Call Today for a FREE Confidential Case Review
Toll-Free 24/7 (866) 920-0753

Study: Starting Testosterone Boosts Blood Clot Risk

December 19, 2016 — Men who use testosterone therapy may have a significantly increased risk of blood clots in the first 6 months of treatment, according to a new study. The study found a 63% increased risk of Venous Thromboembolism (VTE) in the first 6 months after...

Experts: Zofran is Last-Resort for Morning Sickness

December 15, 2016 — Zofran should be a last-resort when other medications have failed to treat morning sickness, according to a review of how to manage nausea and vomiting during pregnancy Experts analyzed several studies investigating the use of Zofran for morning...

Cialis Melanoma Lawsuits Centralized in MDL

December 14, 2016 — Judges have centralized lawsuits involving men who developed melanoma (skin cancer) after taking Cialis or Viagra into one federal court. On December 7, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an order (PDF) sending 10...

Bristol-Myers Squibb to Pay $19.5 Million Abilify Settlement

December 9, 2016 — Bristol-Myers Squibb has agreed to pay a $19.5 million settlement with 43 states for marketing the anti-psychotic drug Abilify for unapproved uses. The settlement places strict rules on how the drug-maker can promote Abilify moving forward, and will...

Invokana MDL Centralizes Lawsuits in New Jersey

December 8, 2016 — Federal judges have centralized nearly 100 lawsuits involving kidney damage, ketoacidosis, and other side effects of Invokana and Invokamet into a Multi-District Litigation (MDL) in New Jersey. The U.S. Judicial Panel on Multidistrict Litigation...

FDA Approves Jardiance to Cut Risk of Cardiovascular Death

December 6, 2016 — The FDA will allow Eli Lilly & Co. to market the diabetes drug Jardiance to reduce the risk of cardiovascular death, but questions remain about other safety risks. Jardiance is the only diabetes drug that is approved to reduce the risk of death...